TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

Deadline Alert: Telix Pharmaceuticals Limited (TLX) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Glancy Prongay & Murray Llp
Deadline Alert: Telix Pharmaceuticals Limited (TLX) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit

Telix Pharmaceuticals faces a class action lawsuit alleging securities fraud after receiving an SEC subpoena and a Complete Response Letter from the FDA regarding its prostate cancer therapeutic candidates, causing significant stock price declines.

Insights
TLX   negative

Company received an SEC subpoena and a FDA Complete Response Letter, which led to substantial stock price drops (10.4% and 16.1%), indicating potential regulatory and developmental challenges with its prostate cancer therapeutic candidates